跳至主要内容
临床试验/IRCT20230211057389N1
IRCT20230211057389N1招募中3 期

Efficacy of Gemfibrozil as an adjusted therapy in obsessive-compulsive disorder in patients with obsessive-compulsive disorder

Karaj University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Having DSM-V diagnostic criteria for obsessive-compulsive disorder
  • ages between 18 to 60

排除标准

  • Abuse of drugs and medicine except nicotine and caffeine
  • Known case of Mental Retardation
  • Presence of other mental disorders
  • The presence of psychotic manifestations
  • Presence of significant medical or neurological disease (advanced kidney disease, CKD, liver disease, cardiovascular disease, and hypertension) and history of gallstones
  • Concomitant use of warfarin
  • Concomitant use of insulin
  • Concomitant use of Statin group
  • Concomitant use of niacin group drugs

研究者

发起方
Karaj University of Medical Sciences

相似试验